Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996086 · ClinicalTrials.gov registry record
Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 154
- Enrollment target
NCT00996086: Completed study, sponsored by Abbott Medical Devices.
NCT00996086 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00996086 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
This is an observational study to learn which patients benefit from CRT therapy and to track the clinical changes that help identify the risk-level of CRT patients.
Interventions
- DEVICE CRT device implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-09 |
What the finished NCT00996086 record still lists
NCT00996086 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CRT device implant is the first listed.
NCT00996086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00996086 about?
NCT00996086 is a clinical study titled "Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)". This is an observational study to learn which patients benefit from CRT therapy and to track the clinical changes that help identify the risk-level of CRT patients.
What is the current status of trial NCT00996086?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2010-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00996086?
The interventions under investigation include: CRT device implant (DEVICE).
Who is sponsoring clinical trial NCT00996086?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia